Results 91 to 100 of about 6,945 (106)

[Cajanonic acid A derivative XJ-60 improves liver fibrosis in mice with non-alcoholic fatty liver disease by inhibiting the SP1/TGF-β/Smad3 signaling axis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Geng Z, Hu L, Dai Y, Luo R, Xu T, Liao X, Yuan Z, Wang J, Xiao Y.   +8 more
europepmc   +1 more source

[Advances in injectable and transdermal glucose-responsive insulin delivery systems]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Li K, Zhang X, Gu Z, Wang J.
europepmc   +1 more source

[Research progress of molecular imprinting technology in the field of disease diagnosis and therapy]. [PDF]

Se Pu
Zhu R, Cai GP, Zheng HJ, Jia Q.
europepmc   +1 more source

[Liver-bone axis: novel mechanisms and strategies for MAFLD regulation]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang YW, Yan XZ, You H, Yang AT.
europepmc   +1 more source

[Bioactive substances delivery for bone repair via nanocomposites: advantages, mechanisms, and emerging trends]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Ma Y, Du Z, Wang J, Li X.
europepmc   +1 more source

[<i>Jiangzhi Quban</i> Recipe improves type 2 diabetes mellitus complicated with hyperlipidemia by multi-target regulation of the inflammation-metabolism network: network pharmacology analysis and clinical validation]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li Z, Zhou F, Sun X, Zhao H, Jin Y, He P, Jia Y.   +6 more
europepmc   +1 more source

[Efficacy analysis of electrochemical detection of leukocyte esterase based on glucosyl ester in diagnosis of periprosthetic joint infection after knee arthroplasty in rabbits]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Luo N, Chen Q, Zeng T, Zuo H, Niu D, Shen B.   +5 more
europepmc   +1 more source

[Chronic myelomonocytic leukemia complicated with T-lymphoblastic lymphoma: a case report and literature review]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Yang YZ, Xu WY, Jiao YJ, Guo ZX.
europepmc   +1 more source

[Central nervous system infection mimicking neuropsychiatric systemic lupus erythematosus: A case report]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Zhao K, Lu F, Wang Y.
europepmc   +1 more source

[Research progress on the pretreatment and analysis of prohibited components of glucocorticoids in cosmetics]. [PDF]

Se Pu
Liu L, Xiao XH, Fang JH, Li GK.
europepmc   +1 more source